TWIST BIOSCIENCE CORP (1TWST.MI) Stock Price, Forecast & Analysis
BIT:1TWST • US90184D1000
1TWST.MI Key Statistics, Chart & Performance
The current stock price of 1TWST.MI is 33.84 EUR.
1TWST.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1TWST.MI.
1TWST.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to 1TWST.MI. 1TWST.MI has a great financial health rating, but its profitability evaluates not so good.
1TWST.MI Financial Highlights
Over the last trailing twelve months 1TWST.MI reported a non-GAAP Earnings per Share(EPS) of -1.8. The EPS increased by 41.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.1% | ||
| ROE | -16.42% | ||
| Debt/Equity | 0 |
1TWST.MI Forecast & Estimates
17 analysts have analysed 1TWST.MI and the average price target is 34.8 EUR. This implies a price increase of 2.85% is expected in the next year compared to the current price of 33.84.
For the next year, analysts expect an EPS growth of 23.93% and a revenue growth 15.05% for 1TWST.MI
1TWST.MI Ownership
1TWST.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1AE | ARGENX SE | 27.89 | 43.962B | ||
| ARGX | ARGENX SE | 27.9 | 43.888B | ||
| 22UA | BIONTECH SE-ADR | N/A | 22.579B | ||
| ABVX | ABIVAX SA | N/A | 8.651B | ||
| 2X1 | ABIVAX SA | N/A | 8.619B | ||
| GXE | GALAPAGOS NV | N/A | 1.957B | ||
| GLPG | GALAPAGOS NV | N/A | 1.948B | ||
| IVA | INVENTIVA SA | N/A | 1.18B | ||
| 6IV | INVENTIVA SA | N/A | 1.174B | ||
| NANO | NANOBIOTIX | N/A | 1.048B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 1TWST.MI
Company Profile
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 979 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The company has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The firm also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The firm's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. The company has minority ownership in Atlas Data Storage, Inc.
Company Info
TWIST BIOSCIENCE CORP
681 Gateway Blvd.
South San Francisco CALIFORNIA US
Employees: 923
Phone: 18007190671
TWIST BIOSCIENCE CORP / 1TWST.MI FAQ
Can you describe the business of TWIST BIOSCIENCE CORP?
Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. The company is headquartered in South San Francisco, California and currently employs 979 full-time employees. The company went IPO on 2018-10-31. The firm's platform's core is a proprietary technology that specializes in manufacturing synthetic DNA by writing DNA on a silicon chip. The company has applied its technology to manufacture a range of synthetic DNA-based products, including synthetic genes, tools for next generation sequencing (NGS) sample preparation, and antibody libraries for drug discovery and development, all designed to enable its customers to conduct research. Its gene products include multiplexed gene fragments, express genes, clonal genes and gene fragments. The firm also manufactures synthetic ribonucleic acid (RNA) as well as antibody proteins. The firm's synthetic DNA tools are used in fields, such as medicine, agriculture, industrial chemicals and defense. The company has minority ownership in Atlas Data Storage, Inc.
What is the current price of 1TWST stock?
The current stock price of 1TWST.MI is 33.84 EUR. The price increased by 14.75% in the last trading session.
What is the dividend status of TWIST BIOSCIENCE CORP?
1TWST.MI does not pay a dividend.
How is the ChartMill rating for TWIST BIOSCIENCE CORP?
1TWST.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Is TWIST BIOSCIENCE CORP (1TWST.MI) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1TWST.MI.
Can you provide the number of employees for TWIST BIOSCIENCE CORP?
TWIST BIOSCIENCE CORP (1TWST.MI) currently has 923 employees.
When does TWIST BIOSCIENCE CORP (1TWST.MI) report earnings?
TWIST BIOSCIENCE CORP (1TWST.MI) will report earnings on 2026-02-02.